search
Back to results

Comparing the Efficacy and Safety of Ultrasound Guided Supraclavicular Block Combined With Either Intercostobrachialor Pec 11for Creation of Surgical Brachio-basilic Fistula in Chronic Renal Failure Patients on Hemodialysis

Primary Purpose

Best Regional Nerve Block for Creation of Surgical Brachiobasilic Fistula

Status
Completed
Phase
Phase 3
Locations
Egypt
Study Type
Interventional
Intervention
regional anesthesia for the upper limb
Sponsored by
Ain Shams University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Best Regional Nerve Block for Creation of Surgical Brachiobasilic Fistula

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • American Society of Anesthesiologists Grade III, age 25-75 years who are scheduled for brachio-basilic AVF.

Exclusion Criteria:

Patients will be excluded if they have infection at the injection site, allergy to local anesthetics, chronic use of opioids, a history of neurological neuromuscular, or severe hepatic or cardiopulmonary disease, a contraindication to regional anesthesia or patient /guardian refusal.

-

Sites / Locations

  • Ain Shams Unuversity Hospitals

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

intercostal group

pecs group

Arm Description

group of patient receiving inrercostal nerve block as analgesia

group of patient receiving pectoralis nerve block as analgesia

Outcomes

Primary Outcome Measures

the proportion of patients with adequate block (no need for intraoperative local infiltration),
ratio

Secondary Outcome Measures

onset of surgical anesthesia
time
duration of postoperative analgesia
time
the failure rate of the fistulae.
Ratio

Full Information

First Posted
March 9, 2020
Last Updated
May 14, 2020
Sponsor
Ain Shams University
search

1. Study Identification

Unique Protocol Identification Number
NCT04311255
Brief Title
Comparing the Efficacy and Safety of Ultrasound Guided Supraclavicular Block Combined With Either Intercostobrachialor Pec 11for Creation of Surgical Brachio-basilic Fistula in Chronic Renal Failure Patients on Hemodialysis
Official Title
Comparing the Efficacy and Safety of Ultrasound Guided Supraclavicular Block Combined With Either Intercosto-brachial Nerve Block or pec11block for Creation of Surgical Brachio-basilic Fistula in Chronic Renal Failure Patients on Hemodialysis
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
April 13, 2019 (Actual)
Primary Completion Date
May 3, 2020 (Actual)
Study Completion Date
May 3, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes

5. Study Description

Brief Summary
In our study we are trying to reach to the more efficient us guided peripheral nerve block either intercosto-brachial or PPEC 11 that can be combined with us guided supraclavicular block to effectively anesthetise the surgical site for creation of brachio-basilic fistula as regarding onset of surgical anesthesia, adequacy of intra-operative anesthesia, the need for surgical wound infiltration, duration of postoperative analgesia and the failure rate of the fistulae.
Detailed Description
Type of Study: Randomized Prospective trail Study Setting: Ain Shams University Hospitals, Cairo, Egypt Study Period: 6 months. Sampling Method: Patients will be subdivided randomly into two groups : Group (SI) : 25 ml of bupivacaine 0.5 % for us guided supraclavicular block plus 10 ml of lidocaine 2% for us guided intercostobrachial nerve block. Group(SP) : 25 ml of bupivacaine 0.5 % for us guided supraclavicular block plus10 ml of lidocaine 2% for us guided PECll block. Study Procedures: Following local university ethical committee approval, informed consent will be obtained. Details of the anesthetic technique and the study protocol will be fully explained at the preoperative visit, and written consent will be obtained from each patient before inclusion in the study. The patients has to have normal prothrombin (PT) and partial thromboplastin (PTT) times before the procedure. In the pre-induction room the patients will be taught how to assess their own pain score using the numerical rating scale (NRS) (0-10; 0 = no pain, 10 = worst imaginable pain) . On arrival at the operating room, standard monitoring will be established with five lead electrocardiogram, non-invasive blood pressure measurement and pulse oximeter. After insertion of a 20-gauge intravenous cannula in the non operated arm, an intravenous crystalloid solution will be administered. Supplemental oxygen will be supplied through nasal cannula. The oxygen flow will be set at 3 L/ min. Patients will receive 1-2 md midazolam intravenous as premedication before the block. All blocks will be performed by one of the authors, The patients will be randomly allocated to one of the two groups, either supraclavicular-intercostobrachial group(SI Group) ,or the supraclavicular-Pec 11 group(SP Group) . The patient in SI Group is placed in a semi-sitting position by elevating the head of bed 45 degrees with the patients head turned to the opposite site to be blocked. The skin of the neck and the upper chest and axilla and medial upper arm will be prepared in an aseptic fashion. Ultrasound examination of the supraclavicular area will be performed using a 38-mm high frequency (9-12 MHz) linear array transducer with the in-plane approach, will receive 25 ml of 0.5% bupivacaine in the supraclavicular area ,then the operated arm will be abducted and externally rotated, and the elbow flexed to 90°. Ultrasound examination of the medial upper arm will be performed using a 38-mm high frequency (9-12 MHz) linear array transducer and the intercosto-brachial nerve is identified and blocked using 10 ml of lidocaine 2% . The patient in SP Group will also have supraclavicular block that will be performed in the same way as the previous group and then patient is placed in the supine position with the arm abducted 90 degrees position to receive Peg 11 lock by injecting 10ml of lidocaine 2% between pectoralis minor and serratus anterior at 3rd rib level using a 38-mm high frequency (9-12 MHz) linear array transducer with the in-plane approach. The sensory and motor blocks will be evaluated every 5 min for 30 min or until blocks will be complete. An adequate surgical anesthesia will be defined as a motor score of ≥1 , with an absence of pinprick sensations in the area of all the four terminal nerves. The zero time for onset of sensory and motor blocks will be the completion of the LA injection. Sensory block assessment (0, no block 1, loss of sensation of pinprick 2, loss of sensation of touch) will be performed in the innervations of the four nerve areas, radial (radial dorsum of the hand), median (thenar eminence), ulnar (hypothenar eminence),and intercostobrachial (medial upper arm) corresponding to the nerve distributions in the forearm and hand using the pinprick test, and will be compared with the same stimulation on the contra-lateral arm. The degree of motor block will be evaluated by thumb abduction (radial nerve), thumb adduction (ulnar nerve), and thumb opposition (median nerve), using a 3-point scale (0 =normal motor function, 1 = decreased motor strength, 2 = complete motor block). The onset times of the sensory block (the time between the end of the LA injection and the total abolition of the pinprick response) and motor block (time between the end of the LA injection and complete motor block) will be recorded for each nerve. Patients who will not achieve satisfactory levels of anesthesia and will need intraoperative local infiltration will be recorded .Patient in whom the block failed and local infiltration is not enough will receive general anesthesia (propofol 2mg/kg plus fentanyl 1ug/kg and atracurium 0.5mg/kg ) with laryngeal mask airway inserted for mechanical ventilation . Postoperative pain will be assessed by one of the authors using a visual analog scale (0, no pain; 10, worst pain imaginable). Analgesic for the first complain of pain will be standardized and consisted of 500 mg of oral or intravenous paracetamol given for a pain score of 4 of visual analog scale.The time to first analgesic requirement will be also recorded by the same author. Heart rate, peripheral oxygen saturation, respiratory rate, and blood pressure will be measured before the supraclavicular block and 5, 10, 20, 30, 45, and 60 min after the block and thereafter every 60 min for 2 h postoperatively. University of Michigan Sedation Scale (UMSS) (1, awake and alert; 2, sedated, responding to verbal stimulus; 3, sedated, responding to strong physical stimulus; 4, not arousable) will be measured first as baseline before the block then at the same time points for measuring vital signs post-block .

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Best Regional Nerve Block for Creation of Surgical Brachiobasilic Fistula

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigator
Allocation
Randomized
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
intercostal group
Arm Type
Active Comparator
Arm Description
group of patient receiving inrercostal nerve block as analgesia
Arm Title
pecs group
Arm Type
Active Comparator
Arm Description
group of patient receiving pectoralis nerve block as analgesia
Intervention Type
Procedure
Intervention Name(s)
regional anesthesia for the upper limb
Intervention Description
pecs-II block and intercostal nerve block
Primary Outcome Measure Information:
Title
the proportion of patients with adequate block (no need for intraoperative local infiltration),
Description
ratio
Time Frame
"through study completion ,an average of one year"
Secondary Outcome Measure Information:
Title
onset of surgical anesthesia
Description
time
Time Frame
"through study completion ,an average of one year"
Title
duration of postoperative analgesia
Description
time
Time Frame
"through study completion ,an average of one year"
Title
the failure rate of the fistulae.
Description
Ratio
Time Frame
"through study completion ,an average of one year"

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists Grade III, age 25-75 years who are scheduled for brachio-basilic AVF. Exclusion Criteria: Patients will be excluded if they have infection at the injection site, allergy to local anesthetics, chronic use of opioids, a history of neurological neuromuscular, or severe hepatic or cardiopulmonary disease, a contraindication to regional anesthesia or patient /guardian refusal. -
Facility Information:
Facility Name
Ain Shams Unuversity Hospitals
City
Cairo
ZIP/Postal Code
11455
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Comparing the Efficacy and Safety of Ultrasound Guided Supraclavicular Block Combined With Either Intercostobrachialor Pec 11for Creation of Surgical Brachio-basilic Fistula in Chronic Renal Failure Patients on Hemodialysis

We'll reach out to this number within 24 hrs